Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis

BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of vision loss in the United States. The most severe vision loss occurs in patients with neovascular AMD, known as wet AMD (wAMD). The most commonly used antivascular endothelial growth factor (VEGF) therapies approved by the FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Luis, Lanitis, Tereza, Cele, Clifford, Toro-Diaz, Hector, Gibson, Andrea, Kuznik, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397814/
https://www.ncbi.nlm.nih.gov/pubmed/29952707
http://dx.doi.org/10.18553/jmcp.2018.24.7.608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397814/
https://www.ncbi.nlm.nih.gov/pubmed/29952707
http://dx.doi.org/10.18553/jmcp.2018.24.7.608

Ejemplares similares